NASDAQ : OACC
Oaktree Acquisition Corp. III Life Sciences — Company profile
Financials · Shell Companies · United States
Last price 10.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 263.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Details
| Name | Oaktree Acquisition Corp. III Life Sciences |
| Sector | Financials |
| Industry | Shell Companies |
| Founded | 2024 |
| Ipo Date | 2024-10-24 |
| Ceo | Zaid Pardesi |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 10.00 |
| Isin | KYG6717R1048 |
| Cusip | G6717R104 |
| Cik | 2029769 |
| Sic | 6770 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Zaid Pardesi | Chief Executive Officer and Director |
| George A. Martinez | Chief Financial Officer, Principal Accounting and Principal Financial Officer |
| Mathew M. Pendo | Chief Operation Officer |
Contact
| Address | 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071, United States |
| Phone | 213 830 6300 |
| Website | https://www.oaktreeacquisitioncorp.com/oac-iii |